Proteins by Design. Software, AI and cell-based screening to discover biologics11-50 Employees
- B2B
- Growth StageExpanding market presence
Cyrus Biotechnology Funding
$0
33 rounds
Cyrus Biotechnology is active in the following markets / industries: biotechnology and pharmaceuticals. The company has secured funding across 3 rounds and is valued at $0. Their most recent funding was raised on July 27, 2017.
Funding Rounds
A
$8000000Series AJul 2017
S
$1300000S
$1425000Investors of Cyrus Biotechnology
Early stage tech VC firm with three-decade track record of investing with heart
Rounds
A
Alok Chanani
Founded USA Commercial (real estate PE group). Army Captain & Unit Commander in Iraq. BA@Cornell-University & MBA@Wharton.
OrbiMed Advisors
Rounds
A
Craig W Philips
Biotech/Pharmaceutical Executive with extensive US and global experience in corporate strategy, M&A, and business development.
The W Fund
Michael Monu
CEO @Barsala
BD @Parallels. Business background.
Also studied EE @Brown University and MBA @Wharton School